Equity Overview
Price & Market Data
Price: $2.16
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $84,550,712
Daily Volume: 0
Performance Metrics
1 Week: 12.50%
1 Month: 10.77%
3 Months: -29.41%
6 Months: -33.54%
1 Year: -36.28%
YTD: -26.78%
Company Details
Employees: 72
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.